Biomarkers and personalised medicine for asthma
- PMID: 30606766
- DOI: 10.1183/13993003.02094-2018
Biomarkers and personalised medicine for asthma
Conflict of interest statement
Conflict of interest: M. Roth has nothing to disclose. Conflict of interest: D. Stolz reports consultancy fees from AstraZeneca and Novartis, and grants from AstraZeneca, Pan Gas, Weimann and Curetis, outside the submitted work.
Comment on
-
"T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin.Eur Respir J. 2019 Jan 3;53(1):1800938. doi: 10.1183/13993003.00938-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30578390
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical